Jim Simons Lantern Pharma Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 65,700 shares of LTRN stock, worth $289,080. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,700
Previous 43,800
50.0%
Holding current value
$289,080
Previous $187,000
209.09%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding LTRN
# of Institutions
38Shares Held
1.07MCall Options Held
124KPut Options Held
22.2K-
Vanguard Group Inc Valley Forge, PA364KShares$1.6 Million0.0% of portfolio
-
New Edge Advisors, LLC New Orleans, LA161KShares$706,3400.01% of portfolio
-
Geode Capital Management, LLC Boston, MA87.4KShares$384,4450.0% of portfolio
-
Cm Management, LLC65KShares$286,0000.5% of portfolio
-
Redmond Asset Management, LLC Henrico, VA40.5KShares$178,0320.12% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $47.7M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...